Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 107.50
-0.50 (-0.46%)
Apr 20, 2026, 1:24 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 168.09 billion as of April 20, 2026. Its market cap has increased by 24.17% in one year.
Market Cap
168.09B
Enterprise Value
163.20B
Revenue
38.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
107.50
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 168.09B, an increase of 2,012.08%. That is a compound annual growth rate of 151.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 168.09B | -30.04% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 49.83B |
| Lin BioScience | 35.82B |
| Oneness Biotech | 26.07B |
| Lumosa Therapeutics | 21.94B |
| Sunmax Biotechnology | 21.65B |
| AP Biosciences | 16.69B |
| Polaris Group | 16.17B |
| Medigen Vaccine Biologics | 15.78B |